Bed Bath & Beyond Inc.
NYSE:BBBYSpecialty Retail
+$0.32 today
- Market cap
- $324.67M
- Beta
- 2.86
- P/E (TTM)
- -6.8
- EPS (TTM)
- -$0.88
Volume 1.33M
Average 3.06M
BBBY EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Bed Bath & Beyond Inc.NYSE: BBBY
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA remains negative
Q1 FY2026 EBITDA was -$12.95M, compared with -$34.87M a year earlier. Trailing-twelve-month EBITDA was -$36.67M.
Context
- EBITDA amounted to 6.5% of revenue in FY2025, down 10.5 pp from a year earlier.
- EBITDA grew in size in 1 of the last 3 fiscal years.
What to watch
Whether EBITDA reaches the consensus estimate from 3 analysts of -$116.37M (-72.4%) for the fiscal year ending Dec 2026, a slowdown from the +71.5% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$12.95M-54.8% QoQ
- Last fiscal yearDec 2025
- -$67.52M+71.5% YoY
- LTMMar 2026
- -$36.67M+82.1% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +62.9% | -66.9% | -129.8 pp |
| 1 year | +71.5% | -72.4% | -143.9 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- (67.52M) USD
- Year-over-year change
- +71.5%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (67.52M) | +71.5% |
| FY2024 | 2024-12-31 | (236.85M) | +3.3% |
| FY2023 | 2023-12-31 | (244.91M) | -1959.7% |
| FY2022 | 2023-02-25 | (11.89M) | -108.1% |
| FY2021 | 2022-02-26 | 147.06M | — |
EBITDA vs competitors
How BBBY compares with its peers on the latest reported figures
- BBBY's LTM Mar 2026 EBITDA of -$36.67M is the lowest of the 11 companies compared; the peer median is $625.62M.
- Its year-over-year change of +82.1% is the 3rd highest of 11, against a peer median of +3.3%.
- EBITDA amounts to 3.5% of revenue for BBBY, versus a peer median of 14.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $3.22B | -10.4% | +4.1% | 27.5% | |
| LTM Aug 2026 | $1.47B | -5.4% | -4.4% | 20.4% | |
| LTM Jun 2026 | $928.91M | +8.2% | +2.0% | 13.9% | |
| LTM Jun 2026 | $701M | -21.9% | +1.2% | 17.1% | |
| LTM Oct 2026 | $637.5M | +289.2% | -39.0% | 11.1% | |
| LTM Jun 2026 | $613.75M | +9.4% | +1.2% | 37.9% | |
| LTM Oct 2026 | $532M | +233.8% | -25.0% | 6.2% | |
| LTM Aug 2026 | $508.43M | +1.9% | -11.3% | 14.7% | |
| LTM Jul 2026 | $422M | +4.6% | +1.8% | 13.7% | |
| LTM Aug 2026 | $323.67M | -54.4% | -18.8% | 6.2% | |
| LTM Mar 2026 | -$36.67M | +82.1% | — | 3.5% | |
| Peer median (excluding BBBY) | $625.62M | +3.3% | -1.6% | 14.3% | |
Competitors are the stored peer set for BBBY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Feb 2022 | FY2022 Feb 2023 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.76B | 1.93B | 1.56B | 1.39B | 1.04B |
| Cost of Revenue | 2.15B | 1.5B | 1.27B | 1.12B | 787.09M |
| Gross Profit | 606.04M | 427.37M | 295.84M | 272.55M | 257.52M |
| Gross Margin | 22.0% | 22.2% | 19.0% | 19.5% | 24.7% |
| Research & Development | 109.2M | 108.93M | 102.74M | 97.43M | 90.28M |
| Selling, General & Admin | 385.77M | 291.44M | 311.21M | 366.09M | 196.93M |
| Operating Expenses | 494.97M | 400.36M | 413.95M | 463.52M | 318.74M |
| Depreciation & Amortization | 23.49M | 21.96M | 19.45M | 19.06M | 16.28M |
| EBITDA | 147.06M | (11.89M) | (244.91M) | (236.85M) | (67.52M) |
| EBITDA Margin | 5.3% | -0.6% | -15.7% | -17.0% | -6.5% |
| Operating Income | 111.07M | 27.01M | (118.11M) | (190.97M) | (61.21M) |
| Operating Margin | 4.0% | 1.4% | -7.6% | -13.7% | -5.9% |
| Interest Income | 1.53M | 2.97M | 13.77M | 8.97M | 6.23M |
| Interest Expense | 2.08M | 0 | 1.76M | 2.2M | 1.17M |
| Other Income / Expenses | 11.94M | (60.86M) | (148.02M) | (67.14M) | (22.58M) |
| Income Before Tax | 123.02M | (33.85M) | (266.12M) | (258.11M) | (83.8M) |
| Pre-Tax Margin | 4.5% | -1.8% | -17.0% | -18.5% | -8.0% |
| Income Tax Expense | (48.78M) | 1.38M | 41.72M | 684K | 825K |
| Net Income | 108.55M | (35.24M) | (307.84M) | (258.8M) | (84.62M) |
| Net Margin | 3.9% | -1.8% | -19.7% | -18.6% | -8.1% |
| EPS (Basic) | 2.51 | (0.80) | (6.81) | (5.56) | (1.41) |
| EPS (Diluted) | 2.49 | (0.80) | (6.81) | (5.56) | (1.41) |
| Weighted Avg Shares | 42.98M | 44.32M | 45.21M | 46.54M | 60.13M |
| Weighted Avg Shares (Diluted) | 43.33M | 44.32M | 45.21M | 46.54M | 60.13M |
Bed Bath & Beyond Inc.
NYSE:BBBY
Intrinsic Alpha fair value
Locked
Current Price
$4.35
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.